Your browser doesn't support javascript.
loading
Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity.
Shim, Man Kyu; Yang, Suah; Park, Jooho; Yoon, Jun Sik; Kim, Jinseong; Moon, Yujeong; Shim, Nayeon; Jo, Mihee; Choi, Yongwhan; Kim, Kwangmeyung.
Afiliación
  • Shim MK; Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
  • Yang S; Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
  • Park J; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Republic of Korea.
  • Yoon JS; Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
  • Kim J; Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
  • Moon Y; Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
  • Shim N; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Republic of Korea.
  • Jo M; Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
  • Choi Y; Department of Bioengineering, Korea University, Seoul, 02841, Republic of Korea.
  • Kim K; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.
J Nanobiotechnology ; 20(1): 436, 2022 Oct 04.
Article en En | MEDLINE | ID: mdl-36195911

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Profármacos / Nanopartículas / Neoplasias / Antineoplásicos Límite: Animals Idioma: En Revista: J Nanobiotechnology Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Profármacos / Nanopartículas / Neoplasias / Antineoplásicos Límite: Animals Idioma: En Revista: J Nanobiotechnology Año: 2022 Tipo del documento: Article